This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Validus' CEO Discusses 1Q 2012 Results - Earnings Call Transcript

If you look at our consolidated segment income statement on Page 12 and 35 in our investor supplement, you’ll see that we present, still, a Validus Re consolidated income statement, which is the summation of Validus Re sub-segment and the AlphaCat sub-segment. This is because when we prepare consolidated Validus Re financial statements, these segments are consolidated within the Validus Re legal entity.

For those of you who wish to measure financial models, you can break what you used to have as Validus Re into these two constituent parts. For those of you who prefer to analyze their business just on Validus Re and Talbot segments, we still provide you with the means to do so. You can call this Validus Re classic. However, effective with the second quarter, we’ll be consolidated PaCRe into the AlphaCat sub-segment, which will add substantially to the (inaudible) AlphaCat. So any work done on your models in advance for second quarter earnings will presumably be well worth it.

For this quarter the main earnings drivers for the AlphaCat segment are fees generated from this activities managing third party capital and the 22.3% equity method income in AlphaCat Re 2011’s earnings. To analyze this component, you’d need to use the 100% AlphaCat Re 2011 income statement. We’ve provided you with this on Page 35 of the supplement, along with the balance sheet on Page 34.

Next quarter we’ll do the same for PaCRe. You’ll need to add the unrealized investment gains or losses for PaCRe as another potentially significant source of earnings for AlphaCat. This would net of a 90% non-controlling interest in the $500 million PaCRe capital base.

For those of you who want to move from modeling our company on a Validus classic basis to our new segmentation, we’ve also furnished an 8-K last evening showing the re-segmentation by quarter for all of 2011.

Read the rest of this transcript for free on

3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.99 0.00%
FB $102.01 0.00%
GOOG $682.40 0.00%
TSLA $151.04 0.00%
YHOO $27.04 0.00%


Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs